Key result
Isolated pleural metastasis with dramatic immunophenotypic shift develops seven years after shoulder synovial sarcoma resection.
Case Report (n=1)
No
This case highlights that synovial sarcoma can present with late, isolated pleural metastasis accompanied by a dramatic immunophenotypic shift, complicating diagnosis.
Late pleural metastases in synovial sarcoma may feature immunophenotypic shifts complicating diagnosis; extends recurrence spectrum but remains hypothesis-generating.
Background Synovial sarcoma is a soft tissue malignancy with a well-known propensity for late recurrence. Pleural metastasis occurring more than five years after primary resection in the absence of pulmonary involvement is exceptionally rare. Case presentation A 42-year-old man underwent local excision of a right shoulder synovial sarcoma in 2019 without adjuvant therapy or follow-up. In June 2026, he presented with right-sided chest pain and progressive dyspnea. Contrast-enhanced chest computed tomography (CT) revealed a massive right pleural effusion with diffuse pleural thickening and no pulmonary nodules; the right shoulder, partially included in the scan field, showed postoperative changes without suspicious masses. Medical thoracoscopy demonstrated pleural adhesions and scattered miliary nodules. Pleural biopsy confirmed a spindle-cell neoplasm. The primary tumour exhibited a classic immunophenotype (Vimentin⁺, Bcl-2 partial⁺, CD99 partial⁺, CK individual⁺, Ki-67 8%). In striking contrast, the pleural metastasis showed a marked immunophenotypic shift: Bcl-2, CD99, and CK turned negative, with only diffuse Vimentin and weak EMA retained, while Ki-67 rose to 50%. After excluding primary pleural spindle-cell neoplasms, a diagnosis of presumed isolated pleural metastasis from synovial sarcoma was made. The patient was started on doxorubicin plus ifosfamide and achieved symptomatic relief sufficient for hospital discharge, but a second cycle could not be administered due to poor performance status. Conclusions This case demonstrates that a dramatic immunophenotypic shift can occur during synovial sarcoma metastasis, posing a significant diagnostic pitfall. It suggests that extended pleural surveillance may be considered in long-term survivors of synovial sarcoma and highlights the importance of direct pathological comparison between primary and metastatic lesions when the immunoprofile appears atypical.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) conducted a case report in Synovial sarcoma with pleural metastasis (n=1). Late pleural metastasis of synovial sarcoma was evaluated on Immunophenotypic shift. A 42-year-old man developed a presumed isolated pleural metastasis with a dramatic immunophenotypic shift seven years after resection of a shoulder synovial sarcoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: